Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

911 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic.
Buonaguro FM, Botti G, Ascierto PA, Pignata S, Ionna F, Delrio P, Petrillo A, Cavalcanti E, Di Bonito M, Perdonà S, De Laurentiis M, Fiore F, Palaia R, Izzo F, D'Auria S, Rossi V, Menegozzo S, Piccirillo M, Celentano E, Cuomo A, Normanno N, Tornesello ML, Saviano R, Barberio D, Buonaguro L, Giannoni G, Muto P, Miscio L, Bianchi AAM; and the INT-Pascale COVID-19 Crisis Unit. Buonaguro FM, et al. Among authors: rossi v. Infect Agent Cancer. 2020 Nov 23;15(1):69. doi: 10.1186/s13027-020-00330-7. Infect Agent Cancer. 2020. PMID: 33292365 Free PMC article.
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes.
Tibaldi C, Mazzoni F, Scotti V, Vasile E, Pozzessere D, Stasi I, Camerini A, Federici F, Meoni G, Caparello C, Turrini M, Rossi V, Ciccone LP, Pecora I, Fantechi B, Antonuzzo L, Giannarelli D, Baldini E. Tibaldi C, et al. Among authors: rossi v. Anticancer Agents Med Chem. 2022;22(7):1278-1285. doi: 10.2174/1871520621666210727112212. Anticancer Agents Med Chem. 2022. PMID: 34315390
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer.
DI Maida F, Grosso AA, Tellini R, Lambertini L, Lo Re M, Cadenar A, Giudici S, Giorgione R, Rossi V, Antonuzzo L, Minervini A, Mari A. DI Maida F, et al. Among authors: rossi v. Minerva Urol Nephrol. 2022 Oct;74(5):642-646. doi: 10.23736/S2724-6051.22.04959-X. Minerva Urol Nephrol. 2022. PMID: 36125025 Free article. No abstract available.
911 results